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Inﬂammation-induced Id2 promotes plasticity
in regulatory T cells
Sung-Min Hwang1,2, Garima Sharma1,2, Ravi Verma1, Seohyun Byun 1,2, Dipayan Rudra1,2 &
Sin-Hyeog Im 1,2,3
TH17 cells originating from regulatory T (Treg) cells upon loss of the Treg-speciﬁc transcription
factor Foxp3 accumulate in sites of inﬂammation and aggravate autoimmune diseases.
Whether an active mechanism drives the generation of these pathogenic ‘ex-Foxp3 TH17’
cells, remains unclear. Here we show that pro-inﬂammatory cytokines enhance the expres-
sion of transcription regulator Id2, which mediates cellular plasticity of Treg into ex-Foxp3
TH17 cells. Expression of Id2 in in vitro differentiated iTreg cells reduces the expression
of Foxp3 by sequestration of the transcription activator E2A, leading to the induction of
TH17-related cytokines. Treg-speciﬁc ectopic expression of Id2 in mice signiﬁcantly reduces
the Treg compartment and causes immune dysregulation. Cellular fate-mapping experiments
reveal enhanced Treg plasticity compared to wild-type, resulting in exacerbated experimental
autoimmune encephalomyelitis pathogenesis or enhanced anti-tumor immunity. Our ﬁndings
suggest that controlling Id2 expression may provide a novel approach for effective Treg
cell immunotherapies for both autoimmunity and cancer.
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Regulatory T (Treg) cells are a unique population of CD4
+ T-
cells essential for maintaining immune homeostasis1–4.
Stable expression of the X-chromosome encoded tran-
scription factor Foxp3 distinguishes Treg cells from other T-cell
lineages5,6, and is a prerequisite for maintaining their suppressive
properties. Functional deﬁciencies in Foxp3 results in overt
lymphoproliferation and systemic autoimmune features both in
mice and human patients characterized by the “scurfy” phenotype
and immunodysregulation polyendocrinopathy enteropathy
X-linked (IPEX) syndrome respectively7,8.
Classically, each CD4+ T helper (TH) subsets are viewed as
terminally differentiated and specialized for their discriminative
functions. However, it has been suggested that plasticity within
effector CD4+ TH cell populations is capable of exerting ﬂexible
immune responses under various physiological conditions9,10.
Several reports have revealed that under inﬂammatory and
autoimmune disease conditions, loss of Foxp3 results in high
degree conversion of Treg cells towards a TH17-like “ex-Foxp3
TH17” phenotype11–15. Consequently, converted ex-Foxp3 TH17
cells become more pathogenic and contribute to the progression
and severity of the disease. The molecular basis of this plasticity
remains to be fully characterized.
Id proteins (Id1-Id4) are inhibitors of helix-loop-helix (HLH)
DNA binding transcription factors and play diverse roles in
immune cell development and function. Id proteins are known to
mainly inhibit DNA-binding activities of E proteins, a prevalent
HLH domain containing family of transcription factors that
include E2A, E2-2, and HEB. Id proteins, which lack any
detectable DNA-binding domain, act by interfering with the
formation of active homo- or hetero-dimers by E-proteins, a
prerequisite for their DNA binding and transcription related
activities16–18.
Together with Id3, Id2 has been shown to be an important
regulator controlling multiple aspects of CD4+ T cell differ-
entiation. Recently published data suggest that Id2 enhances TH1,
but attenuates TFH cell differentiation19. Simultaneous deletion of
Id2 and Id3 results in defect in maintenance and localization, and
enhanced differentiation towards T follicular regulatory (TFR)
subtype of Treg cells20. Furthermore, mice with T cell speciﬁc
deletion of Id2 display resistance towards experimental auto-
immune encephalomyelitis (EAE)21, raising the possibility of its
potential function in TH17 mediated pathogenesis.
Here we show that Id2 is induced in Treg cells under various
inﬂammatory settings. Ectopic expression of Id2 results in
reduced expression of Foxp3 and enhanced TH17 cell-related
cytokines in in vitro induced Treg (iTreg) cells. In mice, Treg cell-
speciﬁc overexpression of Id2 causes Treg instability, and induces
susceptibility to EAE pathogenesis and spontaneous age-related
autoimmunity. IL-1β and IL-6 signaling mediated STAT3/IRF4/
BATF transcriptional activity is found to be responsible for Id2
induction, which in turn inhibits the binding of E2A to the Foxp3
locus, thereby inﬂuencing Treg stability. In a melanoma model of
cancer, temporal overexpression of Id2 in Treg cells suppresses
tumor growth in mice. Our data thus identify a novel cell intrinsic
molecular mechanism underlying Treg cell plasticity with poten-
tial therapeutic signiﬁcance in both autoimmunity and cancer.
Results
Enhanced Id2 expression in ex-Foxp3 TH17 cells. As an initial
approach to identify critical factor(s) that might affect the plas-
ticity of Treg cells, we re-analyzed previously published micro-
array data and compared gene-expression proﬁles of Treg and ex-
Foxp3 TH17 cells14. Since TH17 cells and ex-Foxp3 TH17 cells
have similar phenotypes, albeit being of different origin, we also
used the TH17 cell gene expression proﬁle alongside for this
analysis. We focused on a set of 449 genes which, while are
expressed at a low level in iTreg cells in comparison to TH0, are
de-repressed in TH17 as well as ex-Foxp3 TH17 cells (Supple-
mentary Fig. 1a). Among these, by employing Gene Ontology
(GO) analysis, we focused on the genes that are related to
immune system and /or are involved in regulation of transcrip-
tion (Supplementary Fig. 1b). We identiﬁed Id2 as a putative
target which is most prominently expressed both in ex-Foxp3
TH17 cells and TH17 cells compared to iTreg cells (Supplementary
Fig. 1c). Gene expression data from two other independent stu-
dies also implicated Id2 as a potential target. First, Id2 expression
in ex-Foxp3 TH17 was dramatically increased compared to Treg
cells under inﬂammatory conditions caused by asthma15 (Sup-
plementary Fig. 1d). Second, Id2 expression negatively correlated
with enhanced stability of Rorγt+Foxp3+ Treg cell lineage (Sup-
plementary Fig. 1e)22.
By employing in vitro culture conditions, we next wanted to
determine whether enhanced Id2 expression indeed correlates
with the TH17 or ex-Foxp3 TH17 differentiation process. We
sorted CD4+CD25−CD62LhiCD44lo naive T cells and differen-
tiated them into TH17, iTreg, or ex-Foxp3 TH17 subsets (Fig. 1a).
Indeed, Id2 mRNA was found to be highly induced in TH17 cells
and ex-Foxp3 TH17 cells compared to iTreg cells (Fig. 1b). A time
course analysis to determine Id2 protein expression under similar
experimental conditions revealed that its expression in TH17 cells
commences at 48 h, a time point at which Rorγt expression starts
declining, and TH17 speciﬁc cytokines IL-17A and IL-17F are
expressed most (Fig. 1c). Id2 protein expression in iTreg
differentiation condition however was almost negligible, and the
low level of the protein expressed at earlier time points was
further reduced when detectable expression of Foxp3 and IL-10
was observed (Fig. 1d). More interestingly, under ex-Foxp3 TH17
polarizing condition, Id2 protein expression was found to
gradually increase, mirroring a concomitant reduction in Foxp3
protein level with time (Fig. 1e, upper panel). Furthermore, under
these conditions the cells displayed decrease in IL-10 expression
and an increase in IL-17A expression, suggesting a bonaﬁde
conversion to TH17 phenotype (Fig. 1e, lower panel).
In order to rule out the possibility that the absence of a suitable
marker for Treg cells in the above set of experiments may have
inﬂuenced our interpretation of the results, we also repeated these
experiments by using CD4+CD62LhiCD44loFoxp3Thy1.1− T cells
sorted from Foxp3Thy1.1 reporter mice, in which Thy1.1 allele is
knocked into Foxp3 locus23, as the starting naive population
(Supplementary Fig. 2a). Intracellular staining for relevant
transcription factors and TH17 related cytokines essentially led
to identical conclusions (Supplementary Fig. 2b, c). Furthermore,
including an additional culture condition in which TGF-β was
excluded from ex-Foxp3 TH17 skewing cocktail revealed that
while TGF-β is dispensable for Id2 induction and Foxp3
downregulation, it is required for optimum induction of IL-17A
and subsequent downregulation of IL-10 (Supplementary Fig. 2c).
Rorγt on the other hand appeared to be only minimally induced
only in the presence of TGF-β (Supplementary Fig. 2b).
Id2 promotes iTreg to ex-Foxp3 TH17 differentiation in vitro.
Based on the above results, we hypothesized that Id2 is likely to
negatively affect the differentiation process of iTreg cells, and
examined the effect of Id2 overexpression during TH17 and iTreg
differentiation conditions. Control vector, or a vector encoding
Id2 cDNA were retrovirally transduced in T cells, which were
skewed towards TH17 or iTreg conditions (Supplementary
Fig. 3a). Retroviral expression of Id2 mRNA and protein was
conﬁrmed in transduced cells by RT-qPCR and western blot
analysis respectively (Fig. 2a). Provision of Id2 in TH17 skewing
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condition was found to result in enhanced maintenance of Rorγt
mRNA and protein (Supplementary Fig. 3b, c). IL-17F and IL-22
expressions were also enhanced at mRNA and protein level.
Expression of IL-17A, while increased at mRNA level, was found
to be comparable in terms of protein expression between vector
transduced and Id2 transduced groups at this point, presumably
reﬂecting delayed translation (Supplementary Fig. 3d, e). Con-
versely, under iTreg differentiation condition, Id2 expression
resulted in dramatic reduction in the expression of Foxp3 mRNA
and protein, compared to vector control (Fig. 2b, c). Furthermore,
iTreg cells, in the presence of excess Id2 displayed enhanced
expression of TH1 and TH17 related cytokines IFN-γ, IL-17A, IL-
17F, and IL-22 (Fig. 2d, e). Expression of mRNAs encoding TH2
related cytokines IL-4, IL-5, and IL-13 as well as that of IL-10,
TGF-β, and TNF remained unaltered.
In the above experimental setup T naive cells were differ-
entiated under TH17 or Treg conditions prior to retroviral
overexpression of Id2. In order to rule out any discrepancies
arising from such non-homogeneous culture conditions, we also
performed this experiment under modiﬁed conditions whereby
cells were activated in the absence of any cytokines one day prior
to retroviral transductions. Differentiation was ensued after
retroviral transduction. This differentiation condition appeared
to be suboptimal, particularly for the cells harboring the
retrovirus (GFP+ cells), and resulted in substantially compro-
mised differentiation of the transduced precursors towards
respective effector cell types. Nevertheless, overall conclusions
from these experiments remained the same remained the same
(Supplementary Fig. 4a–g). Taken together, these results indicated
that enhanced Id2 expression leads to unstable iTreg lineage
commitment, and convert them into TH17-like cells.
Treg-speciﬁc ectopic expression of Id2 in vivo. To deﬁne the
functional role of Id2 in regulation of plasticity of Treg cells, we
generated PCMV-lsl-Id2EmGFP mice (Id2EmGFP in short) (Fig. 3a)
in which CMV promoter driven cDNA encoding Id2 fused with
Emerald Green Florescent Protein (EmGFP) is preceded by loxP
ﬂanked mCherry. We crossed Id2EmGFP mice with Foxp3YFP−Cre
mice24 and generated Id2EmGFPFoxp3YFP−Cre mice (Fig. 3a) in
which deletion of the loxP sites would remove the stop codon of
mCherry cDNA, resulting in the expression of Id2-EmGFP fusion
protein speciﬁcally in Treg cells (Fig. 3a, b). Notably, the trans-
gene locus in these mice is also equipped with a Tetracycline
Operator (TetO) sequence, providing it with the provision of
being temporally regulated in a Doxycycline (Dox) dependent
manner upon co-expression of the Tetracycline Repressor protein
(TetR) (Fig. 3a and see later). As a proof of principle, compared
to control Foxp3YFP−Cre, in the Id2EmGFPFoxp3YFP−Cre mice we
observed a shift in the CD4+CD25+ Treg cells towards a GFPhi
population. Expression of Id2 was conﬁrmed in this population
by intracellular staining (Fig. 3c).
Id2EmGFPFoxp3YFP−Cre mice were born at the expected
mendelian ratios and showed no clinical signs of sickness till
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Fig. 1 Id2 expression is enhanced during a conversion to TH17 phenotype from iTreg cells. a In vitro polarization scheme of TH0, TH17, iTreg and ex-Foxp3
TH17 cells. b RT-qPCR analysis of Id2 mRNA in in vitro generated TH0, TH17, iTreg and ex-Foxp3 TH17 cells; results are presented relative to Hprt expression
(n= 3) c, d Western blot analysis to determine the kinetics of indicated proteins during TH17 (c, top panel) and iTreg (d, top panel) cell differentiation and
maintenance conditions. β-actin is used as loading control. RT-qPCR analysis of Il17a, Il17f (c, lower panel) and Il10 (d, lower panel) mRNA during each TH17
and iTreg cell differentiation conditions; results are presented relative to Hprt expression (n= 3). e Sorted CD4+ naive T cells were activated in vitro under
iTreg cell differentiation condition for 3 days. After 3 days, iTreg cells were re-stimulated in vitro in ex-Foxp3 TH17 polarizing conditions for additional 3 days.
Western blot analyses for the indicated proteins were performed after harvesting the cells at indicated time points (top panel). RT-qPCR analysis of Il10 and
Il17a mRNA under similar experimental conditions is shown in the lower panel; results are presented relative to Hprt expression (n= 3). *P < 0.05
(Student’s t-test). Data are representative two independent experiments (error bars, s.d.)
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6–8 weeks of age (Supplementary Fig. 5a). Analysis of these mice
at this age revealed only moderate increase in frequencies and
activation state as determined by CD62LloCD44hi CD4+ and
CD8+ T cell compartments (Supplementary Fig. 5b–d). Further-
more, there was only a marginal decrease in CD4+Foxp3+ Treg
frequency particularly in the peripheral lymphoid organs
(Supplementary Fig. 5e), suggesting that at least under steady
state condition, Treg-speciﬁc ectopic expression of Id2 does not
lead to enhanced loss of Foxp3 at an early age.
To determine whether in contrast to steady state, exposing
young Id2EmGFPFoxp3YFP−Cre mice to inﬂammatory conditions
would lead to enhanced Treg cell plasticity, we next employed a
model of experimental autoimmune encephalomyelitis (EAE), an
animal model for multiple sclerosis in which Treg cell instability
and conversion to effector T cells is well documented13,25,26. For
this we crossed Id2EmGFPFoxp3YFP−Cre mice with mice harboring
R26lsl−tdTomato (R26T in short) locus (resultant mice called
Id2EmGFPR26TFoxp3YFP−Cre or control R26TFoxp3YFP−Cre), in
which the cDNA encoding tdTomato is preceded by stop codon
ﬂanked by loxP sites, and is expressed upon Cre-mediated
recombination. The fate of Foxp3 expression in tdTomato+ cells
in these mice could be determined by monitoring YFP-Cre
expression. Under this experimental condition upon induction of
EAE, as expected even in control R26TFoxp3YFP−Cre mice,
increased Id2 expression was observed in the tdTomato+YFP−
(ex-Treg) cells, compared to tdTomato+YFP+ (Treg) cells,
conﬁrming a correlation between increased Id2 expression and
downregulation of Foxp3 (Fig. 3d, e). Importantly, the extent of
Id2 expression in these ex-Treg cells was comparable to that
observed in Treg cells derived from Id2EmGFPFoxp3YFP−Cre mice,
suggesting that the ectopic Treg speciﬁc expression of Id2 in these
mice remains within physiological limit (compare Id2 expression
in Fig. 3c, e).
Indeed, compared to controls, the Id2EmGFPR26TFoxp3YFP−Cre
mice displayed signiﬁcantly enhanced disease score throughout
the course of the experiment (Fig. 3f, g). This was well correlated
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Fig. 2 Overexpression of Id2 in vitro fails to stabilize iTreg lineage commitment, and convert them into TH17-like cells. a Naive CD4+ T cells were sorted
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with heightened instability of Foxp3 in Id2 expressing cells
speciﬁcally in spinal cord of diseased mice, as determined by
enhanced loss of YFP-Cre expression within tdTomato+ cells in
Id2EmGFPR26TFoxp3YFP−Cre mice compared to controls (Fig. 3h).
Furthermore, Id2 expressing tdTomato+YFP− cells displayed
heightened production of IL-17A, as well as were simultaneous
producers of IL-17A and IFN-γ (Fig. 3i).
These results strongly indicated that ectopic expression of Id2
in Treg cells indeed results in heightened instability of Foxp3
expression. However, provided that under certain activated
conditions naive T cells are known to express Foxp3, albeit in a
transient manner27, there remained a possibility that the
increased frequency of tdTomato+YFP− cells upon Id2 over-
expression is a result of enhanced accumulation of such
promiscuous Foxp3 expressing naive T cells. In order to clarify
this issue, we sorted CD4+FITC−tdTomato−CD44loCD62Lhi
naive T cells from Id2EmGFPR26TFoxp3YFP−Cre or R26TFox-
p3YFP−Cre mice. In order to determine the extent of promiscuous
Foxp3 expression from these cells, they were cultured in the
presence of TGF-β blocking antibody, a condition that was shown
to induce transient Foxp3 induction in vitro27. The extent of
promiscuous Foxp3 expression was found to be identical in
T cells derived from both mice. A control iTreg induction assay in
the presence of TGF-β, as expected, yielded more iTreg cells from
T naive cells derived from R26TFoxp3YFP−Cre (Supplementary
Fig. 6a). Furthermore, when on the other hand, CD4+FITC
+tdTomato+ Treg cells were sorted from these mice and cultured
in vitro, the Treg cells derived from Id2EmGFPR26TFoxp3YFP−Cre
displayed enhanced instability compared to those derived from
R26TFoxp3YFP−Cre mice (Supplementary Fig. 6b). Taken together
these results strongly indicated that Treg speciﬁc ectopic
expression of Id2 results in loss of Foxp3 expression, rather than
increased stability of transient Foxp3+ naive T cells.
While the Id2EmGFPFoxp3YFP−Cre mice showed little immune
dysregulation at a young age, it could be possible that with time
due to prolonged presence of Id2, Treg cells in these mice loose
Foxp3, resulting in visible autoimmune phenotype. In concert to
this hypothesis, indeed at a relatively older age of 12–16 weeks,
these mice developed overt autoimmunity, characterized by
massive splenomegaly and lymphadenopathy (Fig. 4a). Histolo-
gical analysis showed dramatic inﬁltration of lymphocytes into
multiple organs such as skin, lung and liver (Fig. 4b). Notably,
they had increased percentages of CD4+ and CD8+ T cells that
were associated with dramatically increased frequencies of
CD62LloCD44hi effector memory populations (Fig. 4c–e). Impor-
tantly, while CD4+Foxp3+ Treg frequency in the thymus
remained largely intact, Treg cell frequency was found to be
critically reduced in the pLN and spleen of Id2EmGFPFoxp3YFP
−Cre mice (Fig. 4f).
Together, these data strongly suggest an active role of Id2 in
Treg plasticity and pathogenesis accompanied with inﬂammation
caused by autoimmune conditions such as EAE. Furthermore,
while mice with Treg-speciﬁc overexpression of Id2 remains
disease free at an early age, steady loss of Foxp3 expression
eventually results in severely diminished Treg compartment and
results in systemic autoimmunity later in their life.
IL-1β and IL-6 mediated STAT3/IRF4/BATF induce Id2. Next
we sought to determine the cellular and molecular events
responsible for driving Id2 expression in Treg cells under
inﬂammatory conditions. In recent years, the roles of two major
cytokines, IL-1β and IL-6, in driving Treg plasticity resulting in its
phenotypic conversion to TH17-like cells is well documented28–
30. We therefore hypothesized that IL-1β and IL-6 signaling may
induce Id2 expression in iTreg cells. Indeed, in agreement with
this hypothesis we observed that the receptors for both these
cytokines, IL-1r1 and IL-6rα were dramatically upregulated under
in vitro culture conditions speciﬁcally in ex-Foxp3 TH17 cells
derived from Foxp3Thy1.1 mice (in which the Thy1.1 allele is
knocked into Foxp3 locus23) (Fig. 5a). Conversely, when in vitro
differentiated iTreg cells were treated with IL-1β and IL-6, either
by themselves in a dose dependent manner (Supplementary
Fig. 7a), or in combination, resulted in signiﬁcant upregulation of
Id2 transcript and protein expression (Fig. 5b, left panel and 5c).
As expected, this was associated with a concomitant reduction in
Foxp3 mRNA and protein, and enhanced IL-17A expression
(Fig. 5b right panel and Supplementary Fig. 7b). These results
strongly suggested that signaling events downstream of IL-1β and
IL-6 are major contributors to enhanced Id2 expression in ex-
Foxp3 TH17 cells.
In order to determine the transcription factors responsible for
Id2 upregulation, we next re-analyzed published ChIP-seq data
and asked whether any of the ﬁve transcription factors previously
implicated as “core” determinants of TH17 gene expression
program31, is physically associated with Id2 gene locus. Indeed,
among these, STAT3, IRF4 and BATF were found to be strongly
associated to Id2 locus speciﬁcally in TH17 cells, whereas the
bindings for the other two factors Rorγt and Maf were relatively
less prominent (Supplementary Fig. 7c). Further substantiating
this observation, we detected potential binding sites for these
transcription factors throughout the upstream gene regulatory
regions of Id2 transcription start site (TSS) (Fig. 5d). Finally, by
employing luciferase assay based transcription reporter system,
we identiﬁed a speciﬁc region −582 to −147 base pairs upstream
of Id2 TSS to be the key region responsive to these transcription
factors, most effectively in cooperation with each other
(Supplementary Fig. 7d and Fig. 5e, f). Together, these results
indicated that IL-1β and IL-6 signaling-mediated STAT3, IRF4,
and BATF can induce Id2 expression in Treg cells.
Id2 sequesters E2A from binding to Foxp3 promoter. We next
assessed how enhanced level of Id2 in the presence of inﬂam-
matory cytokines might repress Foxp3 expression. Id proteins,
upon forming non-functional heterodimers, are well known
naturally occurring dominant-negative inhibitors of E-protein
transcription activators (e.g., E2A, HEB, and E2-2)16–18. Since
E2A, one of the best characterized members of the E-protein
family, has been previously implicated in promoting transcription
of Foxp3 by being physically associating with multiple regions of
its promoter32, we hypothesized that Id2 de-repression would
potentially sequester E2A, thereby repressing Foxp3 expression.
In agreement with this possibility, unlike Foxp3 and Id2, the
transcript level of the gene encoding E2A was found to be only
minimally affected in iTreg compared to ex-Foxp3 TH17 cells
(Fig. 6a), suggesting a post-transcriptional alteration of E2A’s
activity might be instrumental.
Analysis of the DNA sequences encompassing −1702 to +174
of Foxp3 TSS revealed three strong E-protein binding motifs,
1593−1584, 1295–1286, and 837–829 bps upstream to TSS.
(Supplementary Fig. 8a). ChIP-qPCR analysis conﬁrmed E2A
binding to all of these sites compared to a region with no
predicted E-protein binding motif in iTreg cells (Fig. 6b). More
importantly, the relative occupancy of E2A to all these sites were
signiﬁcantly reduced in ex-Foxp3 TH17 cells, suggesting func-
tional sequestration of E2A in the presence of Id2 (Supplemen-
tary Fig. 8a and Fig. 6b). In agreement to this possibility, in a
luciferase based assay system in which the luciferase reporter gene
was driven by −1702 to +174 bps encompassing Foxp3 promoter,
provision of E2A increased luciferase activity, which was
signiﬁcantly repressed upon co-transfection with Id2 (Fig. 6c).
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Furthermore, mutating the E-box binding motifs rendered the
reporter unresponsive to both E2A and Id2, conﬁrming speciﬁcity
for E2A (Supplementary Fig. 8b and Fig. 6d). Taken together,
these results strongly indicated that increased Id2 can inhibit
Foxp3 expression through modulating E2A accessibility to Foxp3
promoter.
Id2 dependent Treg plasticity enhances antitumor immunity.
Treg cells are known to promote tumor progression by creating an
immunosuppressive tumor environment33–35. Increased Treg cell
numbers and function has therefore been associated with sup-
pression of anti-tumor immunity36,37. Also, a low Treg: Teff ratio
is associated with better prognosis in cancer38–42.
Since we observed increased inﬂammation and age dependent
plasticity of Treg cell populations in peripheral compartment of
Id2EmGFPFoxp3YFP−Cre mice, we tested whether Treg cell-speciﬁc
ectopic expression of Id2 can alter anti-tumor immunity. In order
to implement an experimental scheme in which Treg-speciﬁc
expression of Id2 commences simultaneously with tumor
implantation, we employed an inducible model of temporal
expression of Id2 in Treg cells by crossing Id2EmGFPFoxp3YFP−Cre
mice with PCMV-TetR mice (resultant mouse called TetR-
Id2EmGFPFoxp3YFP−Cre). In this model, under steady state
condition, TetR binds to the TetO, repressing the expression of
Id2-EmGFP protein. Addition of Dox releases this repression
(Fig. 7a, b). Mouse melanoma B16.F10 model was induced and
doxycycline or control PBS was administered according to the
experimental scheme (Fig. 7c). Indeed, Dox-treated mice
exhibited protective effect against tumor growth with signiﬁcant
decrease in tumor weight (Fig. 7d–f). Analysis of tumors revealed
a correlation between reduced tumor volume and increased CD4+
and CD8+ T-cell inﬁltrates in Dox-treated animals (Supplemen-
tary Fig. 9a). More importantly, reduction in tumor progression
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Fig. 4 Treg-cell-speciﬁc overexpression of Id2 results in systemic autoimmunity in older mice. a A representative picture of 12–16 week-old Foxp3YFP−Cre
and Id2EmGFPFoxp3YFP−Cre mice (left) and spleen (SP) and peripheral lymph nodes (pLN) derived from them (right). b Representative hematoxylin and
eosin (H&E)-stained skin, lung, liver sections from 12–16 weeks old Foxp3YFP−Cre and Id2EmGFPFoxp3YFP−Cre mice (scale bar, 100 μm). c Representative
FACS plots and percentages of CD4+ and CD8+ T cells from SP and pLN of 12–16 weeks old Foxp3YFP−Cre and Id2EmGFPFoxp3YFP−Cre mice. d, e
Representative FACS plots and percentages of CD62LhiCD44lo (naive) and CD62LloCD44hi (effector/memory) cells among CD4+ and CD8+ T cells in SP
and pLN 12–16 week-old mice. f Representative FACS plots and percentages of Foxp3+ Treg cells in thymus, SP and pLN from 12–16 week-old mice.
NS, not signiﬁcant, *P < 0.05, **P < 0.005 (Student’s t-test). All data are representative three independent experiments (error bars, s.d.)
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in Dox-treated animals was strongly associated with reduced CD4
+Foxp3+ Treg cell inﬁltration within tumor tissue as well as in
tumor-draining lymph nodes (dLN) (Fig. 7g). CD8+ tumor
inﬁltrating lymphocytes (TILs) as well as CD8+ T cells isolated
from dLN in Dox-treated group had signiﬁcantly higher IFN-γ
expression (Fig. 7h). Consistent with our previous results (Fig. 3i),
Id2 overexpressing Treg cells showed higher IL-17A expression in
TILs and dLN of Dox-treated tumor bearing mice (Supplemen-
tary Fig. 9b). Signiﬁcant increase in the level of IFN-γ and IL-17A
was also observed particularly in CD4+Foxp3− TILs (Supple-
mentary Fig. 9c).
Based on these results, we sought to examine whether ectopic
Id2 expression may negatively affect Treg cell suppressive activity.
Considering the observation that in tumor microenvironment
of Dox-treated mice both CD4+Foxp3− and CD8+ populations
displayed enhanced cytokine production, we performed in vitro
suppression assays with both CD4+ and CD8+ T naive
populations in combination with sorted Treg cells from PBS-
treated or Dox-treated animals (Supplementary Fig. 10a, b).
Indeed Treg cells from Dox-treated mice displayed marginally
reduced suppressive activity against proliferation of both CD4
+Foxp3−and CD8+ T cells (Supplementary Fig. 10b). In
agreement to these results, under identical conditions, the CD4
+Foxp3− cells were found to produce signiﬁcantly increased
level of IFN-γ and IL-17A. Similar trend in cytokine production
was also observed in CD8+ T cells, although the difference did
not achieve signiﬁcance (Supplementary Fig. 10c). Furthermore,
as expected the Dox-treated Treg cells under such culture
conditions displayed enhanced loss of Foxp3 (Supplementary
Fig. 10d), suggesting that at least in part, the defect in suppressive
activity observed in Id2 expressing Treg cells is due to instability
in Foxp3 expression.
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Discussion
Since continuous expression of Foxp3 is required for efﬁcient Treg
function, it is evident that cell intrinsic and extrinsic mechanisms
contributing to stability of Foxp3 are likely to inﬂuence multiple
aspects of immune activation and tolerance in health and disease.
While a number of cis-acting and trans-acting mechanisms have
now been identiﬁed that positively contribute to transcription and
maintenance of Foxp32, whether additional mechanisms exist in
order to negatively inﬂuence Foxp3’s expression in a context
dependent manner, remains less clear. There is increasing evi-
dence suggesting that Treg cells lose their lineage-stability and
convert into diverse effector T cell phenotypes under certain
inﬂammatory and lymphopenic conditions both in human and
mice11,12,14,15,26,43–45. Under these conditions, Treg cells are
readily converted to ex-Foxp3 TH17 cells, impairing immune
homeostasis and exacerbating certain immune disorders. In this
study, by identifying Id2 to be critical for reprogramming Treg
cells towards a TH17 like phenotype in the context of inﬂam-
mation, we have not only deﬁned a hitherto unidentiﬁed
mechanistic switch critical for inducing Treg plasticity, we have
also identiﬁed a novel molecular target that can be potentially
modulated in order to reinforce or undermine Treg stability in the
context of autoimmunity and cancer.
In recent years, several studies demonstrate that TAZ (a
coactivator of TEAD transcription)46 and SGK (serum- and
glucocorticoid-induced kinase 1)47, as well as Socs1 (suppressor
of cytokine signaling 1)48 have critical roles in reciprocally reg-
ulating the differentiation of Treg and TH17 cells. However,
whether and how the expression of these factors is regulated
under conditions promoting Treg plasticity is not fully under-
stood. Here, we showed that Id2 is intrinsically reduced upon
Foxp3 expression in Treg cells while highly expressed in TH17
cells, implying opposite role of Id2 between Treg and TH17 lineage
compartments. In addition, Id2 is signiﬁcantly enhanced during
the conversion of Treg cells into ex-Foxp3 TH17 cells under
inﬂammatory conditions in vitro and in vivo, indicating that Id2
expression is critically associated with conversion of Treg into ex-
Foxp3 TH17 cells.
It is generally recognized that pro-inﬂammatory cytokines,
such as IL-12, IL-1β, and IL-6 are the major contributors pro-
moting inﬂammatory environments suitable for conversion of
Treg cells into different types of ex-Treg cells under conditions of
varied immune disorders such as ocular infection43, helminth
infection49, or autoimmune diseases13–15 (asthma, rheumatoid
arthritis and multiple sclerosis). In particular, IL-1β and IL-6
mediated signaling cascade substantially reduce Treg stability and
enhance the conversion of Treg cells to ex-Foxp3 TH17 cells under
physiological conditions50. We found that Id2 can be induced in
Treg cells upon activation of IL-1β and IL-6 signaling, eventually
leading to reduction in Foxp3 expression and promoting TH17
related cytokine expression. Upon re-analysis of previously pub-
lished high throughput ChIP-seq data, combined with luciferase
assay based transcription analysis we implicated the transcription
factors STAT3, BATF and IRF4, all of which are core members of
the TH17 transcription network, are involved in this process.
However, what factor(s) contribute towards limiting the expres-
sion of Id2 in Treg cells is still unclear. Since green ﬂuorescent
protein (GFP) mediated functional knock-out of Foxp3, results in
upregulation of Id2 in Foxp3GFPKO mice (ref51 and our unpub-
lished data), it seems likely that Foxp3 might act as a direct
repressor of Id2 gene expression. However further experiments
are required to conﬁrm this possibility.
Upon its induction in pro-inﬂammatory conditions, Id2 was
found to repress Foxp3 expression by sequestering the E-box
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binding transcription factor E2A from binding to Foxp3 pro-
moter. E2A, a well-known member of the E-protein family, has
been previously shown to promote transcription of Foxp3 by
physically associating with multiple regions of Foxp3 promoter in
Treg cells32. We found that Foxp3 promoter contains three E-
protein binding sites in which E2A-mediated enhancement of
Foxp3 promoter activity could be signiﬁcantly repressed upon
concomitant expression of Id2. Of note, while well characterized
conserved non-coding sequences (CNS1-3) within the Foxp3
locus have been implicated in various aspects of Foxp3 expression
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as well as maintenance3,5, they did not show any predicted E-
protein binding sites, and were found to be dispensable for Id2
mediated repression of Foxp3 (data not shown). Since Treg cells
make an immunosuppressive tumor microenvironment resulting
in compromised anti-tumor immunity33–35, substantial efforts
are being made to reduce the number or function of Treg cells in
tumor settings38–42. We found that ectopic expression of Id2 in
Treg cells resulted in arrested tumor growth in a B16.F10 mela-
noma model, which was accompanied with loss of Treg cells and
concomitant increase in IFN-γ producing cytotoxic T cells. Fur-
thermore, consistent with our previous results, IL-17A was found
to be signiﬁcantly increased within the CD4+Foxp3− tumor
inﬁltrated lymphocytes, suggesting that these ex-Foxp3 TH17 cells
maintain their ability to produce pro-inﬂammatory cytokine.
Collectively these results suggest that while increased Treg plas-
ticity may result in detrimental cytokine production under
inﬂammatory conditions, proper understanding of molecular
events contributing to such instability can be harnessed in the
context of cancer in order to boost anti-tumor immunity. We
propose therefore that Id2 is one such molecule that can serve as
an attractive target likely to be modulated to implement ther-
apeutic modalities for Treg related disorders in the context or
autoimmune disorders as well as cancer.
Methods
Mice. Foxp3YFP−Cre 24 mice and Foxp3Thy1.1 23 mice are described elsewhere.
PCMV-lsl-Id2EmGFP and PCMV-TetR transgenic mice were generated from Macro-
gen, Inc (Seoul, Korea). ROSA26lsl−tdTomato (R26T) mice were purchased from The
Jackson Laboratory and crossed with conditional Id2 transgenic mice to trace Treg
cells stability and plasticity depend on Treg-speciﬁc Id2 overexpression. All animals
were maintained in a speciﬁc pathogen-free (SPF) conditions at POSTECH animal
facility. All procedures were approved by the POSTECH Institutional Animal Care
and Use Committee (IACUC).
Microarray analysis. Re-analysis was performed on previously published micro-
array gene-expression data14 (Gene Expression Omnibus accession code
GSE48428) to select putative target genes by comparing gene expression proﬁle of
ex-Foxp3 TH17 (ex-Treg) cells with Treg cells. We extracted target gene lists that
were at least 2-folds up-regulated in ex-Foxp3 TH17 cells originated from Foxp3+
T cells (P= 9.29e−92 and TH17 (P= 1.84e−64) compared to Treg cells and at least
2-folds down-regulated in Treg cells (P= 4.97e−59) compared to TH0 cells. Similar
Id2 expression patterns were conﬁrmed from two different independent
studies15,22 (Gene Expression Omnibus accession code GSE80804 and GSE60059
respectively). Data were presented as heat map by using R-Studio.
Flow cytometry and cell sorting. Fixable Viability Dyes (eBioscience) were used
at 1:1000 dilution to label dead cells. For surface staining, cells were stained with
the following ﬂuorescence-conjugated antibodies (eBioscience, Biolegend, Tonbo):
anti-CD4 (RM4-5), anti-CD8 (53–6.7), anti-CD25 (PC61), anti-CD44 (IM7), anti-
CD62L (MEL-14), anti-Thy1.1 (OX-7), IL-1R (JAMA-147), IL-6Rα (D7715A7)
were used at 1:400 dilution. For intracellular staining, surface stained cells were
ﬁxed and permeabilized with a Foxp3 staining kit (eBioscience) according to
manufacturer’s instruction and were stained with the following antibodies: anti-
Foxp3 (FJK-16s), anti-Rorγt (AFKJS-9), anti-Id2 (ab166708; Abcam), anti-IFN-γ
(XMG1.2), anti-IL-17A (TC11-18H10.1), anti-IL-17F (eBio18F10), anti-IL-22
(1H8PWSR), anti-IL10 (JES5−16E3) were used at 1:200 dilution. For intracellular
cytokine staining of cytokines, cells were stimulated by phorbol myristate acetate
(PMA) and ionomycin for 6 h in the presence of Golgi-Plug (555029, BD) or Golgi-
Stop (554724, BD). Data from the stained cells were collected with LSR Fortessa
ﬂow cytometer analyzer equipped with 5 lasers with DIVA software (BD
Biosciences) and were analyzed by FlowJo software (Treestar). Gating strategies for
FACS sorting are described in Supplementary Fig. 11.
In vitro CD4+ T cell differentiation. For CD4+ T helper (TH) cell differentiation,
puriﬁed naive CD4+CD25−CD62LhiCD44lo T cells from wild-type C57BL/6 (B6)
mice or CD4+CD25−CD62LhiCD44loThy1.1− T cells from Foxp3Thy1.1 mice (1 ×
106/ml) were activated with plate-bound αCD3 (1 μg/ml; 1452C11; Bio Xcell) and
αCD28 (2 μg/ml; clone 37.51; Bio Xcell) antibodies in the presence of appropriate
cytokines. TH0: anti-IL-4 (10 μg/ml), anti-IFN-γ (10 μg/ml; XMG 1.2; Bio Xcell)
and 100U/ml of recombinant human IL-2(rhIL-2), TH17: rIL-1β (20 ng/ml), rIL-6
(20 ng/ml), hTGF-β1 (2 ng/ml), anti-IL-4 (10 μg/ml) and anti-IFN-γ (10 μg/ml) or
iTreg: rhIL-2(100U/ml) and human TGF-β1 (hTGF-β1; 5 ng/ml) conditions in T
cell media. 100 U/ml of rhIL-2 (TH0 and iTreg) and 30 U/ml of rhIL-2 and rIL-23
(10 ng/ml) (TH17) were added on 3 days after detaching from αCD3/αCD28
antibodies, and the cells were expanded in complete T cell media additional for
2 days.
RNA extraction and quantitative RT-qPCR. Total RNA was extracted by TRI
Reagent (Molecular Research Center, USA). For reverse transcription, cDNA was
generated using 500 ng of total RNA, oligo(dT) primer (Promega) and Improm-II
Reverse Transcriptase (Promega) in a total volume of 20 μl. One microliter of
cDNA was ampliﬁed by SYBR Premix Ex Taq (Takara, Japan) using DNA Engine
with Rotor-gene Q (Qiagen, Valencia, USA). Mouse hypoxanthine-guanine
phosphoribosyl transferase (HPRT) was used for normalization. All primers used
in this study are summarized in Supplementary Table 1.
Induction and assessment of EAE. Mice were immunized subcutaneously with
200 μg/ml of MOG 33−55 peptide (AnyGen, Korea) with CFA containing 4 mg/ml
heat-killed M. tuberculosis. At 0 days and 2 days, 2 μg/ml of pertussis toxin
suspended in PBS was injected to immunized mice by intraperitoneal injection.
Clinical scores were monitored every other day (0: Normal behavior, 1: Tail
paralysis, 2: Hind legs paralysis, 3: Front legs paralysis, 4: Full paralysis, 5: Death).
Histology. Tissues were ﬁxed in 4% paraformaldehyde. Fixed tissues were
embedded in parafﬁn and sectioned at 3μm thickness, followed by hematoxylin
(Sigma-Aldrich, MO, USA) and eosin (Sigma-Aldrich, MO, USA) (H&E) staining.
The images were captured by Leica DFC425 C microscopy.
Plasmids and retroviral transduction. Retroviruses were produced by transfect-
ing 6 µg of the retroviral expression vector together with 4 µg of the retroviral
packaging vector (pCL-Eco) into Plat-E packaging cells in culture media (DMEM+
10% FBS). Forty-eight hours after transfection, high-titer viral supernatant was
collected. Each differentiating CD4+ T cells was transduced with control (MigR1-
GFP) or Id2 expressing retrovirus (MigR1-Id2-GFP) at 24 h after in vitro stimu-
lation. The transduction was performed in a 12-well plate by spinning for 90 min at
2500 rpm, room temperature in the presence of 8 µg/ml of polybrene. The trans-
duced cells were analyzed 3 days after the start of culture.
Western blot analysis. Cells (1–5 × 106) from in vitro generated TH17, iTreg and
ex-Foxp3 TH17 cells from TNaive (CD4+CD62LhiCD44lo) cells were lysed using
RIPA lysis buffer and separated by SDS-PAGE. Proteins were detected using the
following antibodies: Primary, anti-Mouse Foxp3 (FJK-16s, eBioscience), anti-
Mouse Roγrt (Rorg2, Biolegend), anti-Mouse Id2 (166708, Abcam), anti-Mouse
beta Actin (8226, Abcam); Secondary, anti-Rabbit IgG HRP (AbC-5003, AbClon),
anti-Armenian Hamster IgG HRP (2443, Santa Cruz), anti-Mouse IgG HRP
(AbC5001, Abclon). Images were captured by using a ImageQuantTM LAS4000
(GE Healthcare). Complete scanned gels for western blots are presented in Sup-
plementary Fig. 12.
Plasmids and luciferase reporter assays. HEK-293 T cells or Jurkat cells were
transfected using FuGENE® HD (Promega) or NucleofectorTM (Lonza) according
to the manufacturer’s protocol and plated in 12 well plate. 0.5 μg of the Id2
promoter-luciferase constructs or pGL4.17 empty vector was co-transfected with
Fig. 7 Id2 dependent Treg plasticity enhances antitumor immunity. a Schematic for doxycycline (Dox)-inducible Id2 overexpression in Treg cells in TetR-
Id2EmGFPFoxp3YFP−Cre mice. b Id2 expression was assessed by intracellular staining in SP and pLN from both PBS or Dox treated groups. c Experimental
scheme of mouse melanoma model. Females, 8–10 week-old, TetR-Id2EmGFPFoxp3YFP−Cre mice were injected subcutaneously with B16.F10 cells. Mice were
treated intraperitoneally either with PBS or Dox from day 0–9, every 72 h. d Tumor progression, expressed as mean tumor volume (mm3) in both treatment
groups (PBS; n= 8, Dox; n= 8). e Representative tumor size in PBS and Dox treated groups on d 23. f Difference in tumor weight, as measured at
end point of analysis (PBS; n= 8, Dox; n= 8). g Flow cytometry analysis of CD4+Foxp3+ T cells in tumor-draining lymph nodes (dLN), non-draining
lymph nodes (non-dLN) as well as within tumor inﬁltrated lymphocytes. h Intracellular staining of cytokines in CD8+ T cells isolated from dLN, non-dLN
and tumor inﬁltrated lymphocytes, stimulated with phorbol myristate acetate (PMA) and ionomycin for 6 h. NS, not signiﬁcant, *P < 0.05, **P < 0.005,
***P < 0.001 (Student’s t-test). All data are representative of three independent experiments (error bars, s.d.)
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STAT3 (MR227265; Origene), IRF4 (MR226642; Origene) and BATF (MR222114;
Origene) expression plasmids (HEK-293 T) and 1 μg of the Foxp3 promoter-
luciferase construct was co-transfected with E2A (MG209745; Origene) and Id2
(MR200792; Origene) expression plasmids (Jurkat). Lysates were prepared 30 h
after transfection, and luciferase activities were measured with the Dual-Luciferase
Reporter Assay System (Promega). The reporter activities were normalized to
renilla luciferase activity. Mutations of E2A binding sites were done by using the
GeneArt™ Site-Directed Mutagenesis PLUS System kit (Invitrogen).
Chromatin immunoprecipitation (ChIP). CD4+Foxp3+ iTreg cells (5–7 × 106) or
CD4+Foxp3− ex-Foxp3 TH17 cells originated from iTreg cells (5–7 × 106) were
used. An equal amount of processed chromatin was used as an input control or was
incubated with 4 μg antibody to puriﬁed mouse anti-human E47(G127-32; BD
Biosciences). Immunoprecipitated DNA and total input DNA were analyzed with
SYBR Premix Ex Taq (Takara, Japan) using DNA Engine with Rotor-gene Q
(Qiagen, Valencia, USA). PCR primers for the detection of each Foxp3 promoters
were as follows: Foxp3 amplicon 1 (−411 to −244; No E-box binding sites), 5′-
GGATGCCTTTGTGATTTGAC-3′ (forward) and 5′-TTTGCCCTTTACAAGTC
ATCTG-3′ (reverse); Foxp3 amplicon 2 (−1593 to −1584; E-box BS1), 5′-
GATACCTGGAACTCTTAGCTC-3′ (forward) and 5′-GTCATAGAAGTTCT
AGGACTTGG-3′ (reverse); and Foxp3 amplicon 3 (−1295 to −1286; E-box BS2),
5′-AACAATACAGCCATGATGAGATGGA-3′ (forward) and 5′-GCAAAGGTTT
AGGATTCTAAACAGC-3′ (reverse). Foxp3 amplicon 4 (−837 to −829; E-box
BS3), 5′-TTGCCCTTCTTGGTGATGCT-3′ (forward) and 5′- CATGTTTGTGCT
GAGTGCCC-3′ (reverse).
Mouse melanoma model. To establish in vivo mouse tumor model, 0.2 × 106 B16.
F10 cells, obtained from American Type Culture Collection (ATCC, USA) were
subcutaneously injected in the ﬂank region, on day 0. Inducible Id2 transgenic mice
(TetR-Id2EmGFPFoxp3YFP−Cre) were treated with intra-peritoneal injections of
either PBS or Doxycycline (50 μg/g mice in 200 µl) on day 0, 3, 6, and 9 to induce
Id2 expression in Treg cells. Tumor growth was monitored on alternate days, from
day 15 through day 27 post tumor cells injection. Vernier calipers were used for
measuring length and width of the tumors and tumor volume was calculated using
formula Volume (mm3)= (length × width × width)/2. Euthanasia was performed
at the end of experiment or if tumor volume exceeded 2000 mm3 or the tumor
growth obstructed the feeding of mice.
In vitro suppression assay. CD4+Foxp3+ Treg cells sorted from PBS and Dox
treated mice were washed three times with PBS and incubated with responder cells
(CD45.1+CD62LhiCD44loFoxp3−CD4+ or CD8+) that were pulsed in 1 ml of PBS
with 1uL of a 5 μM CTV stock for 10 min at 37 °C. CTV labeled cells were washed
in PBS twice and immediately used. 1 × 105 APC depleted of CD4 and
CD8 splenocytes by negative selection (Miltenyi Biotech) were mixed with 5 × 104
CTV-pulsed Foxp3−CD4+ or CD8+ responder cells. Treg and responder cells ratio
used as indicated within the ﬁgure along with 0.4μg/ml of anti-CD3 in a round
bottom 96-well plate. Cultures were incubated for 4 days and then analyzed by ﬂow
cytometry to determine CTV dilution as well as intracellular staining for cytokines
after stimulation with phorbol myristate acetate (PMA) and ionomycin for 6 h in
the presence of Golgi plug.
Statistical analysis. Statistical tests were performed using Prism 7.03 software
(GraphPad). Signiﬁcant differences were measured by unpaired, two-tailed Stu-
dent’s t-test with a 95% conﬁdence interval. Statistical signiﬁcance was considered
as P < 0.05 (*<0.05, **<0.005, ***<0.001).
Reporting Summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Previously published microarray data supporting the ﬁndings of this study have
been deposited in the Gene Expression Omnibus and are publicly available under
the GEO accession number GSE48428, GSE80804 and GSE60059. All data that
support the ﬁndings of this study are available from the corresponding authors
upon request.
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